Real‐world opportunity of empagliflozin to improve blood pressure control in African Americans with type 2 diabetes: An NCDR® “research‐to‐practice” project from the Diabetes Collaborative Registry (DCR)
Arnold SV et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13510
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.